They further showed its significantly enhanced anti-cancer effect in DX2/K-RasLA2 double-transgenic (DK) mice when treated together with GN25, inhibiting the binding of p53-Snail [96] or with Adriamycin, having antimitotic and cytotoxic activity in various cancer cells [18,97]. Here, TP53 is linked to cancer.